Liver Cirrhosis, Biliary

Obeticholic Acid

Obeticholic acid is a medication prescribed for the management of primary biliary cholangitis. This educational activity covers the indications, mechanism of action, contraindications, FDA-issued box warnings, adverse event profile, toxicity, and critical aspects such as dosing, monitoring, and relevant drug interactions associated with obeticholic acid. Reviewing pharmacological information regarding obeticholic acid is essential for healthcare professionals looking to enhance treatment for patients with primary biliary cholangitis. This knowledge supports informed decision-making while initiating obeticholic acid regimens and minimizing adverse reactions to ensure targeted, safe, personalized care. The session also highlights the importance of the interprofessional healthcare team in managing obeticholic acid therapy effectively. By clarifying roles and promoting collaboration, healthcare professionals may achieve optimal obeticholic acid administration, improving patient outcomes and care standards.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.